Latest News & Updates
Breaking News
7 hours ago
Vaibhavi M.
Other trending news you may like to read
Japan Approves Regeneron And Sanofi’s Dupixent For Bullous Pemphigoid Following Strong Phase 2/3 Remission Results
Regeneron and Sanofi gain Japan approval for Dupixent in bullous pemphigoid, showing improved remission in Phase 2/3 trial for moderate-to-severe autoimmune skin disease.
Vaibhavi M.
Amylyx Completes Phase 3 Enrollment For Avexitide In Post-Bariatric Hypoglycemia, Data Expected 2026
Amylyx Pharmaceuticals completes Phase 3 enrollment for avexitide in post-bariatric hypoglycemia, advancing Breakthrough Therapy-designated drug with topline data expected in Q3 2026.
Vaibhavi M.
Ocugen Reports Positive Phase 2 Data for OCU410 Gene Therapy In Geographic Atrophy, Plans Phase 3 Trial Advancing Toward Registration
Ocugen reports Phase 2 success for OCU410 gene therapy in geographic atrophy, showing reduced lesion growth and advancing toward Phase 3 trial for dry age-related macular degeneration.
Vaibhavi M.
Thermo Fisher Closes $8.9 Billion Clario Deal To Strengthen Clinical Trial Data And Biopharma Services Portfolio
Thermo Fisher Scientific completes $8.9B acquisition of Clario to enhance clinical trial data solutions, strengthening biopharma services and accelerating drug development analytics capabilities.
Vaibhavi M.
